Answers are grounded in this paper and cite their sources.
Patterns of use of secondary prevention medications after stroke/TIA are not optimal, with many survivors discontinuing treatment within 1 year postdischarge. Improving postdischarge care for patients with stroke/TIA is needed to minimize unwarranted discontinuation.
No takes yet. Share an insight, caveat, or question.
Dalli et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: